Regular and intensive use of cannabis and related problems: Some results from literature and from the 2002 REITOX reports (CT.2003.103.P1) Roland Simon.

Slides:



Advertisements
Similar presentations
TREATMENT DATA INDICATORS IN THE UNODC DATA COLLECTION SYSTEM.
Advertisements

The validity of diagnoses for clients with primary cannabis related problems in out-patient treatment Roland Simon IFT, Munich Lisbon, TDI Annual Expert.
1 TDI &Prevalence First results of pilotproject A.W.Ouwehand W.Kuijpers Lisbon: TDI meeting september 2006.
The EMCDDA and the Reitox network: towards quality achievement Sandrine Sleiman, Scientific Committee, Palmela, February 2008.
Women in treatment in the Czech Republic Běla Studničková, M. D., Vladimír Polanecký, M. D. Drug Epidemiology Headquarters Hygienic Station of the Capital.
Etienne Maffli Swiss Institute for the Prevention of Alcohol and other Drug Problems Lausanne, Switzerland Characteristics of male and female outpatients.
TDI meeting Lisbon 23rd and 24th of June Stichting Informatievoorziening Zorg - Randhoeve Postbus GH Houten.
Treatment Demand Data: a breakdown by gender in some EU countries Linda Montanari, Colin Taylor, Lisbon, September 2004 Annual Expert Meeting on.
REPORT Full report Executive summary Methodology STATISTICAL ANNEX Seizures Drug use Prices Illicit laboratories.
An investigation of the controversies surrounding human rights of patients with ADHD Dr. Pooria Sarrami Foroushani M.D. School of Sociology & Social Policy.
SAMH Mental Health & Alcohol Conference Transforming the concept of Dual Diagnosis to the concept of Complex Needs Dr Fraser Shaw Consultant Psychiatrist.
2 emcdda.europa.eu European drug report package A comprehensive analysis on the drugs problem in Europe.
Heavy or problematic drug use, heavy and problematic to define? Iceland August 2010, Nordic Alcohol and Drug Researchers’ Assembly Ellen J. Amundsen,
S.T.A.R.T. Cuyahoga County Department of Children and Family Services Sobriety Treatment and Recovery Teams.
Overview of the 2010 work programme Paul Griffiths, Roland Simon, Rosemary de Sousa Scientific Committee meeting, Lisbon, November 2009.
Buprenorphine Treatment: Care Coordination Indications and Options James Schuster, MD, MBA Chief Medical Officer Community Care.
TYPES OF MENTAL ILLNESS. OVERVIEW DEPRESSION ANXIETY SUBSTANCE ABUSE.
TYPES OF MENTAL ILLNESS. “NEUROSES” NO BREAK WITH REALITY DEPRESSION, ANXIETY, SUBSTANCE ABUSE VERY COMMON CONTINUOUS NOT DISCRETE MUCH CO-MORBIDITY.
Advanced Briefing to Member States
ARQ part II data management Training pack 1: Content and conceptual issues.
Panic and Generalized Anxiety Disorder. Basic Info  Generalized Anxiety Disorder, GAD, is an anxiety disorder characterized by chronic anxiety, exaggerated.
Internet-based interventions — messages that click Dr. Peter Tossmann delphi-Gesellschaft für Forschung, Beratung und Projektentwicklung mbH, Berlin EMCDDA.
COMORBIDITY IN ADDICTION AND OTHER MENTAL ILLNESSES The Chiromo Lane Medical Centre (CLMC) Approach.
Manju Mehta & Rajesh Sagar Department of Psychiatry A ll I ndia I nstitute of M edical S ciences, New Delhi Mental health problems have been a concern.
An EMCDDA view on recovery Roland Simon Head of Unit Intervention, Best Practice, and Scientific Partners.
Quality Assurance at the European Monitoring Centre for Drugs and Drug Addiction Sandrine Sleiman European Conference on Quality in Official Statistics,
Jennifer Hillebrand, „Rehabilitation of Drug Addicted Persons: Experience of Lithuania and European Countries”, 18 October 2007 Improving drug treatment.
Treatment system-based data collection: an integrated approach to monitoring Expert meeting: Implementation of the treatment strategy EMCDDA Lisbon,
CO-MORBITITY RESEARCH IN ADDICTION SCIENCE International Round Table ICAA MEETING MAGDEBURG May 23 rd, 2008 DR. THOMAS LEGL KUR UND GESUNDHEITSZENTRUM.
Annual report 2009: the state of the drugs problem in Europe International Conference: New trends in drug use: facts and solutions, Parliament of the Republic.
Trends and developments Selected trends and some insights in prevention Vilnius, 12 November 2014 Roland Simon.
Overview of Drug Control in Foreign Countries. Drug Control in EU A. Policy Trends ■ Decriminalisation of possession of small amount of drugs for personal.
YOUTH AND ALCOHOL ABUSE. Objectives To provide understanding of alcoholism To provide information about substance abuse prevention. To assist students.
“Problem, intensive drug use and polydrug use” Introduction Danica Klempova, Scientific Committee meeting, Lisbon, 17 November.
Chapter 3 Addictions: Theory and Treatment. Drug Addiction Behavioral pattern of drug use Overwhelming involvement Securing of its supply Tendency to.
An overview of European trends and developments Roland Simon ECAD Meeting 2011, Varna.
Drug and Alcohol Treatment for offenders – What Works? Mike Trace Chief Executive RAPt (Rehabilitation of Addicted Prisoners Trust)
Twinning Project Implementation of Strategy for Fight Against Drugs in Serbia Kick off and Assessment November 2012 Belgrade.
Revision of Problem Drug Use indicator Danica Klempová and Julián Vicente 42nd Reitox HFP meeting, 27 May 2010.
An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009.
An update on local services. The big picture… New Horizon’s has been launched; Better mental well-being Right help – right time Improved services Tackling.
C. Donald Williams M.D.1 “Group Therapy in the Treatment of Injured Workers” 1997 APA Annual Meeting Current Uses of Group Therapy C. Donald Williams,
Institut für Therapieforschung München Institut für Klinische Psychologie und Psychotherapie „Insights“ publication concept Therapeutic communities and.
PRINCIPLES OF DRUG ADDICTION TREATMENT Dr. K. S. NJUGUNA.
Linda Montanari, Buenos Aires, October 2003 CICAD/OAS, Demand Reduction Experts Group Meeting The Information System on Treatment Demand in EU EMCDDA.
EMCDDA Work Programme Key Issue 1: Key Indicators 30th Meeting of Scientific Committee J Vicente (together with D Olszewski, D Klempova, L Montanari,
Drugs and Substances YDAP Giuseppe Furno May 2011.
Epidemiology of addictive disorders: a brief review MRCPsych addiction psychiatry seminar series Dr Stuart McLaren 2 nd March 2012.
Treatment Prevalence Project Background information Expert meeting Implementation of the treatment strategy – Module 1: TDI prevalence 24 June 2013.
 ARC Under 18’s Substance Misuse Programme 160A Sunshine Industrial Estate Crumlin Road Crumlin Dublin 12 Presented by:Jimmy Norman.
Overview of EMCDDA’s 2009 Scientific Work Programme Paul Griffiths, Roland Simon - REITOX Meeting, Lisbon, November 2007.
Section 5: Principles of Drug Addiction Treatment 1.
EMCDDA Treatment data collection strategy - progress report May 09 Dagmar Hedrich, on behalf of the TWG Presentation at the meeting of the Scientific Committee,
Monitoring and reporting on the drug phenomenon in Europe EMCDDA mandate and activities Wolfgang Götz, Scientific Committee, Palmela, 14 February 2008.
Collaboration between the national EWS and treatment service providers in Hungary Anna Péterfi Hungarian National Focal Point TAIEX seminar Zagreb,
Overview of the cannabis use in Europe Paul Griffiths, Reitox academy, Berlin, 29th March 2007.
Alcohol and Drug Problem in Poland. Implications for policy Janusz Sierosławski Institute of Psychiatry i Neurology 3rd Meeting of the Expert Group on.
Client characteristics and treatment needs (CARED-Project)*
Drug addiction: Therapeutic problems in everyday clinical practice
Accessing Cannabis Users – Survey on Good Practice Approaches
Cannabis epidemic or return of opoid problems or decrease of high risk drug use among young adults in Austria Addictions Lisbon 2017, Paper Session 2 –
World Drug Report June 2015.
First year assessment of the French « cannabis outpatients clinics »
MENTAL HEALTH and SUBSTANCE MISUSE
Decriminalisation Policy and the role of the CDT
Medication use and misuse among illicit drug users in France Lisbon Addictions 2017 Paper session 31: Spotlight on the misuse of medicines Aurélie Lermenier-Jeannet.
Linda Montanari Programme P1: Monitoring the Situation
Utilizing Peer Supports in the Community
Skopje, 21 November 2017, General Population Survey results– launch
EU Drugs Action Plan: Guidelines and standards
Presentation transcript:

Regular and intensive use of cannabis and related problems: Some results from literature and from the 2002 REITOX reports (CT P1) Roland Simon Lisbon, TDI Annual Expert Meeting, September 2004

Contents 2/14 Problematic use of cannabis is defined in different studies through:  Concept “Frequent or regular use”  Some results from recent research: framework  Results from NFP Reports 2002: Prevalence, Treatment  Conclusions

Antecedent factors of PCU 3/14

Chronic effects of PCU 4/14

Secondary effects of PCU 5/14

Prevalence 6/14

Clients characteristics I 7/14

Clients characteristics II 8/14

Overview: Situation  Prevalence: - Dependence: 0,2-3% - Misuse3% - Frequent Use1-6% - Regular Use4-10%  Characteristics - Msle years old - problems with school and social achievements - psychiatric comorbidity: anxiety, depression, psychosis - multiple drug use 9/14

Treatment demands 10/14

Treatment needs and referrals 11/14

Special treatments offered 12/14

Overview Treatment  Referrals: - Justice plays a big role: 20-25% - Majority is self-referred, partly motivated by the family - Frequent Use1-6% - Regular Use4-10%  Trends - Up to 50% ( most countries: 10-20%) of out-patiente clients come mainly for cannabis - Increase in most of the Member States over the last years  Treatment needs - No mix with opiate addicts - Little specific treatment programmes, additional elements very important 13/14

Conclusions In relation to the topic cannabis in treatment - there seem to be a relevant and increasing number of clients asking for help - while cannabis is the main substance in these cases, often other drugs are used as well - additional aspects (school achievements, psychiatric problems..) play a import role in treating this group - treatment offered in most countries looks less developed and sophisticated than for heroin addicts In relation to TDI and “Problematic drug use” - common definitions needed for this client group - possible basis: frequency of use, consequences of use 14/14